Clinical Trial Update: Exclusive Enteral Nutrition vs. Infliximab in Chinese CD Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing Exclusive Enteral Nutrition with infliximab in Chinese patients with Crohn's disease was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Exclusive Enteral Nutrition
• Infliximab (infliximab)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Crohn's Disease, Exclusive Enteral Nutrition | Phase 4 | Status: WITHDRAWN